Friday, July 15, 2016

UPDATE 1-Valeant psoriasis drug's suicide risk hard to assess -FDA Staff

July 15 (Reuters) - Valeant Pharmaceuticals International

Inc's experimental drug to treat the skin disorder

psoriasis carries a potential risk of suicide that is

challenging to assess due to limited...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)